Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience

CONCLUSION: There are limited studies published on the efficacy and post-treatment toxicities of metastatic breast cancer OM and OP SABR with adequate length of follow-up. This study confirmed that SABR was a safe, non-invasive treatment option for patients with extracranial OM and OP diseases originated from primary breast cancer in terms of the acceptable post-treatment toxicities.PMID:38575431 | DOI:10.1016/j.clon.2024.03.012

Source: Cancer Control - April 4, 2024 Category: Cancer & Oncology Authors: S Armstrong A Makris K Belessiotis-Richards M Abdul-Latif P Ostler N Shah D Miles Y M Tsang Source Type: research